HNF‐1β expression and ARID1A loss have been suggested as a biomarker for O‐CCC, although its role in tumor progression remains largely unknown.24 NUCOLL43 were negative for HNF‐1β but positive for ARID1A by Western blot. The gene discussed is ARID1A; the disease is neoplasm.